Phase 3 Atherosclerosis Clinical Trials
13 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Chronic Kidney DiseaseAtherosclerosis Cardiovascular Disease
Eli Lilly and Company7,140 enrolled568 locationsNCT07241390
Recruiting
Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Peripheral Arterial DiseaseInflammationAtherosclerosis of Extremities
Population Health Research Institute6,150 enrolled70 locationsNCT04774159
Recruiting
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Phase 2Phase 3
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Stroke, IschemicIntracranial Atherosclerosis
National University of Singapore130 enrolled1 locationNCT07282041
Recruiting
Phase 3
Specifying the Anti-inflammatory Effects of Ziltivekimab
AtherosclerosisInflammation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)40 enrolled1 locationNCT06263244
Recruiting
Phase 3
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Stroke, IschemicStrokeAtherosclerosis+5 more
Assistance Publique - Hôpitaux de Paris2,800 enrolled1 locationNCT05476991
Recruiting
Phase 3
The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin
AtherosclerosisDyslipidemia
Wenzhou Medical University240 enrolled1 locationNCT02726555
Recruiting
Phase 3
Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
Cardiovascular DiseasesDiabetesAtherosclerosis+1 more
Ottawa Heart Institute Research Corporation115 enrolled2 locationsNCT04181996
Recruiting
Phase 3
The effect of Colchicine on Cardiovascular Outcomes in Stroke Study (The CASPER Study)
AtherosclerosisIschemic StrokeTransient Ischemic Attack
University of Sydney1,500 enrolled9 locationsACTRN12621001408875
Recruiting
Phase 2Phase 3
Do stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular (CV) rIsk?
Coronary atherosclerosisPolygenic risk
Monash University600 enrolled6 locationsACTRN12620001166965
Not Yet Recruiting
Phase 3
Coronary Atherosclerosis Progression with Testosterone InterVEntion (CAPTIVE)
Coronary atherosclerosisCoronary atheroma
The University of Western Australia558 enrolled1 locationACTRN12620000100998
Recruiting
Phase 3
The effect of Colchicine on Cardiovascular Outcomes in Acute Coronary Syndrome Study (The COLCARDIO-ACS Study)
AtherosclerosisIschaemic heart disease
University of Sydney3,000 enrolled16 locationsACTRN12616000400460
Completed
Phase 3Phase 4
The effect of the antiplatelet drug Prasugrel on the interactions between immune cells and the blood clotting cells platelets in patients with cardiovascular disease.
Atherosclerosis
Capital and Coast District Heath Board24 enrolled1 locationACTRN12612001157864